Sentiment Survey
|
|
|
|
|
|
|
|
|
|
|
|
Investment Grade:
|
|
Comments(0)
|
(0)
|
(0)
|
Ranking History
Headlines
- Helix BioPharma Files Form 20-F Registration Statement With the U.S. Securities and Exchange Commission
Nov 25, 2008 06:45 PM
- Helix BioPharma Files Form 20-F Registration Statement With the U.S. Securities and Exchange Commission
Nov 25, 2008 06:44 PM
- Helix BioPharma Presents Preclinical L-DOS47 Data at The Second Conference of Lung Cancer in Warsaw, Poland
Nov 19, 2008 09:01 AM
- Helix BioPharma Presents Preclinical L-DOS47 Data at The Second Conference of Lung Cancer in Warsaw, Poland
Nov 19, 2008 09:00 AM
- Huttig Building Products, Inc. Announces Third Quarter 2008 Results
Oct 30, 2008 06:01 PM
- Helix BioPharma Corp. Announces Fiscal 2008 Results
Oct 28, 2008 05:35 PM
- Helix BioPharma Corp. Announces Fiscal 2008 Results
Oct 28, 2008 05:34 PM
- Huttig Building Products to Host Third Quarter 2008 Conference Call on Friday, October 31, 2008 at 11 AM Eastern (10 AM Central)
Oct 16, 2008 12:00 PM
- Helix Biopharma Closes $11.4 Million Private Placement
Oct 02, 2008 04:42 PM
- Helix Biopharma Closes $11.4 Million Private Placement
Oct 02, 2008 04:41 PM
Analyst Ratings
|
|
Share Performance
|
Period
|
HBP
|
Compare to S&P
|
| YTD |
-88.54 %
|
-0.01 %
|
| 4 Weeks |
-66.67 %
|
-60.50 %
|
| 12 Weeks |
-84.91 %
|
-78.22 %
|
|
Financial Ratios
Earnings Performance
|
EPS Growth in Last Quarter: -236.36 %
|
|
EPS Growth in Last Year: -0.01 %
|
|
Sales Growth in Last Quarter: -6.45 %
|
|
Sales Growth in Last Quarter: -21.55 %
|
|
|
